Systemic complement profiling in multiple sclerosis as a biomarker of disease state

Complement regulator factor H as a serum biomarker of multiple sclerosis disease state

(2010) Gillian Ingram et al.   BRAIN

Elevated plasma C4a levels in multiple sclerosis correlate with disease activity

(2010) Gillian Ingram et al.   JOURNAL OF NEUROIMMUNOLOGY

A longitudinal study of MRI-detected atrophy in secondary progressive multiple sclerosis

(2010) J. Furby et al.   JOURNAL OF NEUROLOGY

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

(2009) C. E. Teunissen et al.   NEUROLOGY

Complement in multiple sclerosis: its role in disease and potential as a biomarker

(2008) G. Ingram et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapies

(2008) Michael K Racke   CURRENT OPINION IN NEUROLOGY

Campath 1-H treatment in patients with aggressive relapsing remitting multiple sclerosis

(2008) C. L. Hirst et al.   JOURNAL OF NEUROLOGY

Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis

(2008) C Hirst et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

B cells and multiple sclerosis

(2008) Diego Franciotta et al.   LANCET NEUROLOGY

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis

(2008)   NEW ENGLAND JOURNAL OF MEDICINE